Elan Foxman
@Shay Capital Llc
Latest period2024 - Q3ReportedManaged Assets$707.795MTotal holdings264
Assets growth rate-2.31%Assets growth rate (2-Q avg)5.25%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Shay Capital Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 264 positions.
Assets under management
The assets under management (AUM) of Shay Capital Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 707.795M in assets, with a quarterly growth rate of -2.31% and a 2-quarter average growth rate of 5.25%. The portfolio is managed by Elan Foxman, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
GPCRStructure Therapeutics Inc
| 0.06% | $373,065 8,500 shares@ $43.89 avg price | Increased 21.43% |
QUREUniqure Nv
| 0.06% | $370,815 75,216 shares@ $4.94 avg price | Increased 7.92% |
INAQInsight Acquisition Corp
| 0.05% | $328,649 29,007 shares@ $11.33 avg price | Increased 131.58% |
HYMCHycroft Mining Holding Corp
| 0.05% | $324,773 129,909 shares@ $2.51 avg price | Increased 0.2% |
OKLOOklo Inc
| 0.05% | $324,498 40,111 shares@ $8.1 avg price | Increased 118.64% |
TRVITrevi Therapeutics Inc
| 0.05% | $313,833 93,962 shares@ $3.34 avg price | Increased 6.22% |
ACADAcadia Pharmaceuticals Inc
| 0.05% | $283,500 18,433 shares@ $15.39 avg price | Increased 14.95% |
PMVPPmv Pharmaceuticals Inc
| 0.04% | $280,196 188,051 shares@ $1.5 avg price | Increased 13.7% |
3016⤦Exela Technologies Inc
| 0.04% | $228,894 143,059 shares@ $1.6 avg price | Increased 3.69% |
VRMMQVroom Inc
| 0.03% | $156,798 16,734 shares@ $9.38 avg price | Increased 28.17% |